Search

Your search keyword '"CALIENDO, DOMENICO"' showing total 6 results
Start Over Author "CALIENDO, DOMENICO"
6 results on '"CALIENDO, DOMENICO"'

1. Dissecting the mechanisms and molecules underlying the potential carcinogenicity of red and processed meat in colorectal cancer (CRC): an overview on the current state of knowledge

Author

Cascella, Marco, primary, Bimonte, Sabrina, additional, Barbieri, Antonio, additional, Del Vecchio, Vitale, additional, Caliendo, Domenico, additional, Schiavone, Vincenzo, additional, Fusco, Roberta, additional, Granata, Vincenza, additional, Arra, Claudio, additional, and Cuomo, Arturo, additional

Published
2018
Full Text
View/download PDF

2. Anesthetic dreaming, anesthesia awareness and patient satisfaction after deep sedation with propofol target controlled infusion: A prospective cohort study of patients undergoing day case breast surgery

Author

Cascella, Marco, primary, Fusco, Roberta, additional, Caliendo, Domenico, additional, Granata, Vincenza, additional, Carbone, Domenico, additional, Muzio, Maria Rosaria, additional, Laurelli, Giuseppe, additional, Greggi, Stefano, additional, Falcone, Francesca, additional, Forte, Cira Antonietta, additional, and Cuomo, Arturo, additional

Published
2017
Full Text
View/download PDF

3. Enhanced recovery pathways in colorectal surgery: a consensus paper by the Associazione Chirurghi Ospedalieri Italiani (ACOI) and the PeriOperative Italian Society (POIS).

Author

FICARI, FERDINANDO, BORGHI, FELICE, CATARCI, MARCO, SCATIZZI, MARCO, ALAGNA, VINCENZO, BACHINI, ILARIA, BALDAZZI, GIANANDREA, BARDI, UGO, BENEDETTI, MICHELE, BERETTA, LUIGI, BERTOCCHI, ELISA, CALIENDO, DOMENICO, CAMPAGNACCI, ROBERTO, CARDINALI, ALESSANDRO, CARLINI, MASSIMO, CASCELLA, MARCO, CASSINI, DILETTA, CIOTTI, SIMONA, CIRIO, ANGELA, and COATA, PAOLA

Published
2019

4. Erratum to: Multidisciplinary approach and anesthetic management of a surgical cancer patient with methylene tetrahydrofolate reductase deficiency: a case report and review of the literature

Author

Cascella, Marco, primary, Arcamone, Manuela, additional, Morelli, Emanuela, additional, Viscardi, Daniela, additional, Russo, Viera, additional, De Franciscis, Silvia, additional, Belli, Andrea, additional, Accardo, Rosanna, additional, Caliendo, Domenico, additional, De Luca, Elena, additional, Di Caprio, Barbara, additional, Di Sauro, Francesco, additional, Giannoni, Giovanni, additional, Iermano, Carmine, additional, Maciariello, Maria, additional, Marracino, Marcella, additional, and Cuomo, Arturo, additional

Published
2015
Full Text
View/download PDF

5. Multidisciplinary approach and anesthetic management of a surgical cancer patient with methylene tetrahydrofolate reductase deficiency: a case report and review of the literature

Author

Cascella, Marco, primary, Arcamone, Manuela, additional, Morelli, Emanuela, additional, Viscardi, Daniela, additional, Russo, Viera, additional, De Franciscis, Silvia, additional, Belli, Andrea, additional, Accardo, Rosanna, additional, Caliendo, Domenico, additional, De Luca, Elena, additional, Di Caprio, Barbara, additional, Di Sauro, Francesco, additional, Giannoni, Giovanni, additional, Iermano, Carmine, additional, Maciariello, Maria, additional, Marracino, Marcella, additional, and Cuomo, Arturo, additional

Published
2015
Full Text
View/download PDF

6. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer

Author

Bimonte S, Cascella M, Leongito M, Palaia R, Caliendo D, Izzo F, and Cuomo A

Subjects
Animals, Antineoplastic Agents, Phytogenic administration & dosage, Antineoplastic Agents, Phytogenic pharmacokinetics, Apoptosis drug effects, Biological Availability, Catechin administration & dosage, Catechin pharmacokinetics, Catechin pharmacology, Disease Progression, Disease-Free Survival, Humans, Pancreatic Neoplasms pathology, Signal Transduction drug effects, Tea chemistry, Antineoplastic Agents, Phytogenic pharmacology, Catechin analogs & derivatives, Pancreatic Neoplasms drug therapy
Abstract

Human pancreatic cancer is one of the leading causes of mortality and morbidity worldwide. Despite surgical resection remains the only curative therapeutic treatment for this disease, only the minority of patients can be resected due to late diagnosis. Recently, new chemotherapy schemes with the combination of different drugs have been shown to improve disease-free survival, although best results were obtained mostly as neoadjuvant chemotherapy in the minority of patients with resectable tumor. Consequently, there is stimulated interest in new chemotherapeutic approaches and alternative medicines. Several studies showed that the use of natural compounds, such as phytochemicals, represents a promising strategy for pancreatic cancer treatment. One popular phytochemical with great anticancer properties, is the (-)-epigallocate-chin3-O-gallate (EGCG), the most abundant catechin found in green tea. Accumulating evidences demonstrated that EGCG induces apoptosis and inhibits tumor progression by modulating different signaling pathways in pancreatic cancer. For these encouraging results, this catechin is currently used in clinical trials for treatment of various type of cancer and other diseases, although its poor bioavailability and poor stability represent severe limitations. Therefore, many researchers tried to develop a new strategy based of the use of nanotechnology which increases EGCG stability and bioavailability and simultaneously targets cancer cells in order to improve its anti-tumor effects. The aim of this article is to dissect the use of EGCG for management of pancreatic cancer, by reviewing the pre-clinical studies reported in literature.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results